Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one ...
Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...
8h
Current heart attack screening tools fail to identify half the people who are at risk, study shows
Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...
Once-weekly semaglutide 2.4 mg reduced the risk for major adverse cardiovascular events among adults with overweight or obesity who were at risk for atherosclerotic cardiovascular disease, according ...
Asianet Newsable on MSN
New Drug Cuts Bad Cholesterol by Nearly 60% in First-Year Trials
Discover Enlicitide, a new daily pill for genetic high cholesterol (HeFH). A recent trial shows it lowers bad LDL cholesterol ...
NEW ORLEANS, LOUISIANA / ACCESS Newswire / November 12, 2025 / American Heart Association (“AHA”) Conference 2025, GENinCode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback